...
首页> 外文期刊>Bone marrow transplantation >Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: A prospective study
【24h】

Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: A prospective study

机译:验证同种异体BMT住院非专业护理伙伴支持对患者生存的积极影响:一项前瞻性研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This prospective study validates the finding from retrospective research that having an inpatient lay care-partner (CP) is associated with better survival following allogeneic BMT. Compared with patients without a CP (n=76), patients with a CP (n=88) have significantly better OS (P=0.017) and relapse-free survival (RFS) (P=0.020). Four-year and median survivals were 42% and 36 months among patients with CPs, compared with 26% and 10 months among those without CPs. Four-year survival and median RFS were 39% and 25 months among those with CPs, compared with 23% and 7 months among those without CPs. Further, better survival and RFS were associated with CP visit duration of >3 h per day (P=0.005 and P=0.007, respectively) and with CP frequency of visits >75% of inpatient days (P=0.004 and P=0.010, respectively). A CP support program should encourage not only presence of a CP but also duration and frequency of CP visits associated with better patient survival.
机译:这项前瞻性研究验证了回顾性研究的发现,即同种异体BMT可使住院的专业护理伙伴(CP)与更好的生存率相关。与没有CP的患者(n = 76)相比,患有CP的患者(n = 88)的OS(P = 0.017)和无复发生存(RFS)(P = 0.020)明显更好。 CPs患者的四年和中位生存期分别为42%和36个月,而没有CPs的患者则为26%和10个月。有CP的患者的四年生存率和中位RFS分别为39%和25个月,而没有CP的患者为23%和7个月。此外,更好的生存率和RFS与每天> 3 h的CP访问持续时间(分别为P = 0.005和P = 0.007)以及CP访视频率>住院天数的75%(P = 0.004和P = 0.010,分别)。 CP支持计划不仅应鼓励CP的存在,还应鼓励CP访视的持续时间和频率,以提高患者的生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号